News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–54
- Matches
- 54
- Sources here
- 8
- Companies here
- 2
Search results
Stored financial headlines
Active search
54 matching headlines
Ticker or company: TXGMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
10x Genomics, CHUV Expect Hundreds of Patients in Cancer Study
10x Genomics announced a multi-year research collaboration with Lausanne University Hospital (CHUV) to advance diagnostic applications of single cell and spatial technologies in cancer care. The study aims to identify clinically relevant biomarkers for predicting treatment response and prognosis across various solid tumors using …
TXG
main company
Sharemaestro market context
Trend signal active
52 weeks +292.2% · Next-week setup positive 62.5%
10x Genomics Inc Class A Revenue Breakdown – GETTEX:1KJ
This article details the revenue breakdown for 10x Genomics Inc Class A (GETTEX:1KJ). In the last fiscal year, the company generated 547.31 million EUR, with the Consumables - Single Cell segment contributing the most at 309.24 million EUR. The United States was the largest …
TXG
main company
Sharemaestro market context
Trend signal active
52 weeks +292.2% · Next-week setup positive 62.5%
Cathie Wood Dumps $39 Million Worth of AMD Stock
This article first appeared on GuruFocus. Cathie Wood's ARK Invest reduced its position in Advanced Micro Devices (NASDAQ:AMD) during the week ended July 17, making the chipmaker its largest sale of the period. ARK sold approximately $39.2 million of AMD shares as part of …
TXG
main company
Sharemaestro market context
Trend signal active
52 weeks +292.2% · Next-week setup positive 62.5%
ETFs Investing in 10x Genomics Inc Class A Stocks
This article lists the various Exchange Traded Funds (ETFs) that hold 10x Genomics Inc Class A (TXG) stocks. It provides a detailed table including fund names, market value of TXG holdings, weight in the fund, issuer, management style, expense ratio, AUM, price, change, relative …
TXG
main company
Sharemaestro market context
Trend signal active
52 weeks +292.2% · Next-week setup positive 62.5%
TXG Stock Rallies As Wall Street Hikes Price Targets
10x Genomics Inc. (TXG) stock has rallied by 9.43% due to strong demand for its single-cell platform and increased price targets from Wall Street analysts. Barclays, Morgan Stanley, and Citi have all raised their price targets for TXG, indicating improved sentiment for life science …
TXG
main company
Sharemaestro market context
Trend signal active
52 weeks +292.2% · Next-week setup positive 62.5%